Sibold William John
CEO
Latest Insider Transactions
8 transactions (past 365 days)
| 2026-03-06 | 2026-03-06 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Sale | 1,663 | $431.94 | $718,316 |
| 2026-03-06 | 2026-03-04 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Award | 18,743 | $0.00 | $0 |
| 2026-03-06 | 2026-03-04 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Award | 14,995 | $0.00 | $0 |
| 2025-12-04 | 2025-12-04 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Sale | 2,400 | $575.34 | -$1,380,816 |
| 2025-12-04 | 2025-12-03 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Exercise Conversion | 50,000 | $0.00 | $0 |
| 2025-09-09 | 2025-09-09 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Sale | 7,279 | $445.63 | -$3,243,741 |
| 2025-08-21 | 2025-08-21 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Sale | 1,131 | $401.00 | -$453,531 |
| 2025-08-21 | 2025-08-21 | MDGL Madrigal Pharmaceuticals, Inc. | CEO | Sale | 6,485 | $400.04 | -$2,594,227 |
MDGL
CEO
Sale
$718.3K
1,663 shares @ $431.94
Filed 2026-03-06Trade 2026-03-06
Madrigal Pharmaceuticals, Inc.MDGL
CEO
Sale
-$1.4M
2,400 shares @ $575.34
Filed 2025-12-04Trade 2025-12-04
Madrigal Pharmaceuticals, Inc.MDGL
CEO
Exercise Conversion
$0
50,000 shares @ $0.00
Filed 2025-12-04Trade 2025-12-03
Madrigal Pharmaceuticals, Inc.MDGL
CEO
Sale
-$3.2M
7,279 shares @ $445.63
Filed 2025-09-09Trade 2025-09-09
Madrigal Pharmaceuticals, Inc.MDGL
CEO
Sale
-$453.5K
1,131 shares @ $401.00
Filed 2025-08-21Trade 2025-08-21
Madrigal Pharmaceuticals, Inc.MDGL
CEO
Sale
-$2.6M
6,485 shares @ $400.04
Filed 2025-08-21Trade 2025-08-21
Madrigal Pharmaceuticals, Inc.